Search results
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 4 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Pfizer Inc. (NYSE:PFE) Shares Sold by Trust Co. of Vermont
ETF DAILY NEWS· 1 day agoTrust Co. of Vermont lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the fourth quarter, according to the company in its most recent filing ...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 days agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 2 days agoThis underperformance of Pfizer stock can be attributed to declining revenues after the surge in Covid-19 vaccine demand during the pandemic ...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 11 hours agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 5 days agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and ...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via AOL· 4 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 1 day agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc, ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) for its updated JN.1 COVID-19 vaccine, NVX-CoV2705, for...